BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 2016
View Archived Issues
Prothena reports phase Ib results for PRX-002 in Parkinson's disease
Read More
FDA removes partial clinical hold on NY-ESO SPEAR study
Read More
Retrophin reaches SPA agreement with FDA for phase III trial of RE-024 for PKAN
Read More
Galectin Therapeutics looking for potential strategic partnership for GR-MD-02
Read More
Selecta Biosciences gets worldwide rights to candidates generated through Sanofi collaboration
Read More
FDA approves Opdivo for head and neck cancer
Read More
Blisibimod CHABLIS-SC1 phase III study does not achieve primary endpoint
Read More
FDA approves Vemlidy to treat chronic HBV infection
Read More
Assembly Biosciences starts phase Ia/Ib trial of ABI-H0731
Read More
FDA grants BTD to Seattle Genetics' brentuximab vedotin
Read More
Omeros reports nonhuman primate data for MASP-3 inhibitor OMS-906
Read More
NAALADL2 identified as a drug target for prostate cancer
Read More
Celsion reports positive data for OVATION phase Ib trial
Read More
Capricor expands CAP-1002 clinical development program in DMD
Read More
RedHill Biopharma concludes type B meeting with FDA for RBH-105 phase III program
Read More
TaiMed Biologics notifies Theratechnologies of preliminary results for phase III trial of ibalizumab
Read More
VRC-01 only slightly delays HIV rebound in clinical studies
Read More
Aptinyx wins USD 2.85 million in research grants
Read More
Bristol-Myers Squibb licenses rights to Nitto Denko's siRNA molecules
Read More
Jiangsu Hansoh Pharmaceutical patents FXR agonists
Read More
Chinese researchers report CDK/cyclin inhibitors for cancer
Read More
BGI-Shenzhen develops of calcium channel blockers
Read More
Inhibikase Therapeutics describes tyrosine kinase inhibitors
Read More
Synaptic biomarkers of cognitive decline identified in patients with dementia
Read More
Genmab to test daratumumab in combination with carfilzomib and dexamethasone in MM patients
Read More
Glucagon/thyroid hormone conjugate improves experimental metabolic conditions
Read More
Lilly's Lartruvo gets conditional approval in Europe for advanced soft tissue sarcoma
Read More